CERo Therapeutics Holdings, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERO and other ETFs, options, and stocks.

About CERO

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.

CEO

Christopher B. Ehrlich

CEOChristopher B. Ehrlich

Employees

—

Employees—

Headquarters

Oakland, California

HeadquartersOakland, California

Founded

2021

Founded2021

Employees

—

Employees—

CERO Key Statistics

Market cap

4.93M

Market cap4.93M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

7.61M

Average volume7.61M

High today

$1.09

High today$1.09

Low today

$0.8134

Low today$0.8134

Open price

$0.9602

Open price$0.9602

Volume

1.90M

Volume1.90M

52 Week high

$171.00

52 Week high$171.00

52 Week low

$0.5338

52 Week low$0.5338